Respiratory disease tests are required for the diagnosis of any chronic or acute respiratory disorder. The diagnosis of respiratory function is done either by understanding the anatomy of the respiratory organs, or by determining the respiratory capabilities of the lungs. A majority of respiratory tests are designed either to identify obstructions in the respiratory tract, or to observe the efficiency of the lungs in exchanging respiratory gases. Equipment used to detect pulmonary abnormalities hold immense potential due to increasing prevalence of various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pneumonia. This research report on the respiratory disease testing market explains various advancements in this market and analyzes the global respiratory disease testing market based on device type, end-user, and geographic regions. This report comprises an elaborate executive summary, which includes a market snapshot that provides market dynamics of various segments and sub-segments that are included in the report in a precise manner.

A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global respiratory disease testing market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis and Porter’s Five Forces analysis and key players’ market share analysis in 2013 in the respiratory disease testing market. The research report also provides value chain (distribution) analysis from the supplier of the raw material to the end-users (hospital, physician offices, and clinical laboratories).

Browse full report at : http://www.transparencymarketresearch.com/respiratory-disease-testing.html


Based on type of test, the global respiratory disease testing market has been segmented into imaging test, spirometry, peak flow test, blood gas test, lung volume test, and other tests. The market for these tests has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers. The market size and forecast in terms of USD million for each technology has been provided for the period from 2012 to 2022. The report on the respiratory disease testing market also provides % compound annual growth rate (CAGR) for each of the market segment and sub-segment mentioned above for the forecast period from 2014 to 2022, considering 2013 as the base year.

Based on end-user, the global respiratory disease testing market has been segmented into hospitals, physician offices, and clinical laboratories. The market for these end-users of respiratory disease testing has been extensively analyzed based on installation rate and utilization of the devices in hospitals, physician offices, and clinical laboratories. The market size and forecast in terms of USD million for each segment has been provided for the period from 2012 to 2022. The report on the respiratory disease testing market also provides % compound annual growth rate (CAGR) for each market segment and sub-segment for the forecast period from 2014 to 2022, considering 2013 as the base year.


Browse the full Press Release: http://www.transparencymarketresearch.com/pressrelease/respiratory-disease-testing.htm

Geographically, the respiratory disease testing market has been categorized into North America, Europe, Asia-Pacific, Latin America, Middle East North Africa, and Rest of the World (RoW). The market size and forecast for each of these regions have been provided for the period from 2012 to 2022 along with CAGR (%) for the forecast period from 2014 to 2022. The research study also incorporates the competitive scenario of major players in these regions.

A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase their market shares. The report concludes with the profiles of major players in the respiratory disease testing market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players profiled in this report include Philips Healthcare, GE Healthcare, CareFusion Corporation, Cosmed, ndd Medical Technologies, Inc., and SDI Diagnostics.

The global respiratory disease testing market is segmented as follows:
Global Respiratory Disease Testing Market, by Test
Imaging Tests
Spirometry Tests
Peak Flow Tests
Blood Gas Tests
Lung Volume Tests
Other Tests
Global Respiratory Disease Testing Market, by End-user
Hospitals
Physician Offices
Clinical Laboratories
Global Respiratory Disease Testing Market, by Geography
North America
U.S.
Canada
Europe
U.K.
Germany
Rest of Europe
Asia-Pacific (APAC)
Japan
China
Rest of APAC
Latin America (LATAM)
Brazil
Mexico
Rest of LATAM
Middle East North Africa (MENA)
Saudi Arabia
UAE
Rest of MENA
Rest of the World

Request a Brochure of this : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1288


About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools anDescriptiond techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.


Contact

Mr. Nachiket Ghumare
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com